HANANE CHAIBAINOU: Open Payments
NPI 1316241565 · WESTAMPTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,718 in 140 payments from 25 companies in 2025. Trend: 2023 $330 · 2024 $1,671 · 2025 $13,718
Travel & lodging: $10,668Food & beverage: $3,050
| Company | Payments | Amount |
|---|---|---|
| InSightec,Inc | 2 | $10,668 |
| ABBVIE INC. | 40 | $667 |
| UCB, Inc. | 14 | $478 |
| PFIZER INC. | 12 | $279 |
| Lundbeck LLC | 10 | $250 |
| Axsome Therapeutics, Inc. | 7 | $201 |
| Lilly USA, LLC | 4 | $156 |
| SCILEX PHARMACEUTICALS INC. | 8 | $128 |
| Neurocrine BioSciences, Inc. | 7 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
Products named: Exablate, UBRELVY, NURTEC ODT, Fintepla, QULIPTA, Symbravo, ZEPOSIA, Rystiggo.
Industry payments across NJ — which companies pay providers there.
